These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33566186)

  • 1. Interim 4'-[methyl-
    Mitamura K; Norikane T; Yamamoto Y; Fujimoto K; Takami Y; Hoshikawa H; Toyohara J; Nishiyama Y
    EJNMMI Res; 2021 Feb; 11(1):13. PubMed ID: 33566186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of volumetric 4'-[methyl-
    Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y
    Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
    Ito K; Yokoyama J; Miyata Y; Toyohara J; Okasaki M; Minamimoto R; Morooka M; Ishiwata K; Kubota K
    Nucl Med Commun; 2015 Mar; 36(3):219-25. PubMed ID: 25369751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CT.
    Hotta M; Minamimoto R; Toyohara J; Nohara K; Nakajima K; Takase K; Yamada K
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2615-2623. PubMed ID: 33438100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 4'-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study.
    Hotta M; Minamimoto R; Yamada K; Nohara K; Soma D; Nakajima K; Toyohara J; Takase K
    EJNMMI Res; 2019 Jan; 9(1):10. PubMed ID: 30701347
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Minamimoto R; Takeda Y; Hotta M; Toyohara J; Nakajima K; Naka G; Sugiyama H
    EJNMMI Res; 2019 Jan; 9(1):4. PubMed ID: 30649637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-[methyl-
    Fukuda Y; Yamamoto Y; Mitamura K; Ishikawa R; Asano E; Toyohara J; Norikane T; Nishiyama Y
    Ann Nucl Med; 2019 Nov; 33(11):822-827. PubMed ID: 31401773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Vos JL; Zuur CL; Smit LA; de Boer JP; Al-Mamgani A; van den Brekel MWM; Haanen JBAG; Vogel WV
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2010-2022. PubMed ID: 34957526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of the Volumetric Parameters of Dual-Time-Point
    Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H
    AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426
    [No Abstract]   [Full Text] [Related]  

  • 10. Texture indices of 4'-[methyl-
    Ihara-Nishishita A; Norikane T; Mitamura K; Yamamoto Y; Fujimoto K; Takami Y; Ibuki E; Kudomi N; Hoshikawa H; Toyohara J; Nishiyama Y
    Eur J Hybrid Imaging; 2020 Nov; 4(1):20. PubMed ID: 34191155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma.
    Minamimoto R; Barkhodari A; Harshman L; Srinivas S; Quon A
    PLoS One; 2016; 11(4):e0153321. PubMed ID: 27123976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer.
    Minamimoto R; Toyohara J; Seike A; Ito H; Endo H; Morooka M; Nakajima K; Mitsumoto T; Ito K; Okasaki M; Ishiwata K; Kubota K
    J Nucl Med; 2012 Feb; 53(2):199-206. PubMed ID: 22190643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
    Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma.
    Albano D; Re A; Tucci A; Giubbini R; Bertagna F
    Ann Nucl Med; 2019 Apr; 33(4):280-287. PubMed ID: 30788775
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang P; Li Z; Wang D; Ma F; Zhang R; Liang W; Sun M; Fu Z; Sun X
    Oncol Lett; 2018 Feb; 15(2):1845-1852. PubMed ID: 29434881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.
    Minamimoto R; Nakaigawa N; Nagashima Y; Toyohara J; Ueno D; Namura K; Nakajima K; Yao M; Kubota K
    Abdom Radiol (NY); 2016 Mar; 41(3):521-30. PubMed ID: 27039323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.
    Kim KR; Shim HJ; Hwang JE; Cho SH; Chung IJ; Park KS; Kang SR; Kwon SY; Chung WK; Bae WK
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):170-178. PubMed ID: 28940101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.